Can you recognize a patient at risk for a hypercoagulable state?
Platt
Allan
A
Department of Family and Preventive Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
D000925:Anticoagulants / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D019851:Thrombophilia / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000502:physiology / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D010959:Tissue Plasminogen Activator